Axa’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-15,100
| Closed | -$126K | – | 1261 |
|
|
2021
Q4 | $126K | Sell |
15,100
-20,700
| -58% | -$173K | ﹤0.01% | 1134 |
|
|
2021
Q3 | $266K | Buy |
35,800
+15,600
| +77% | +$116K | ﹤0.01% | 1154 |
|
|
2021
Q2 | $137K | Sell |
20,200
-47,600
| -70% | -$323K | ﹤0.01% | 1232 |
|
|
2021
Q1 | $696K | Buy |
67,800
+14,400
| +27% | +$148K | ﹤0.01% | 1037 |
|
|
2020
Q4 | $374K | Hold |
53,400
| – | – | ﹤0.01% | 1106 |
|
|
2020
Q3 | $436K | Sell |
53,400
-20,200
| -27% | -$165K | ﹤0.01% | 1059 |
|
|
2020
Q2 | $508K | Hold |
73,600
| – | – | ﹤0.01% | 1056 |
|
|
2020
Q1 | $350K | Hold |
73,600
| – | – | ﹤0.01% | 1026 |
|
|
2019
Q4 | $643K | Buy |
+73,600
| New | +$643K | ﹤0.01% | 956 |
|